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VKORCI WITH ISCHEMIC ATHEROTHROMBOTIC STROKE 
 
Harbuzova Ye. A., student; MI SumDU, gr. 404 
 
Annually Stroke affects 16 million people and causes the death of nearly 
6 million. 88%  of all strokes account for ischemic stroke genesis. 
Disorders in processes of hemostasis and ectopic calcification play the 
important role in ischemic atherothrombotic stroke development. Today 
distinguished the group of vitamin K-dependent proteins that includes 
proteins, which provide hemostasis and proteins that have anticalcifications 
properties. Residues of glutamic acid, that are the part of structure of 
vitamin k-dependent proteins, must be carboxylase during the 
posttranslation modification for the activation of proteins. This reaction is 
catalyzed by enzyme g-glutamyl carboxylase. Vitamin K is a cofactor in 
this reaction and it is oxidized from the vitamin K hydroquinone to 2.3 
epoxide vitamin K. Enzyme, which restores of vitamin K epoxide to 
vitamin K hydroquinone is called vitamin K epoxide reductase. Vitamin K 
epoxide reductase is integral transmembrane protein. It plays the important 
role in vitamin K-dependent protein activation. VKORC1 gene is localized 
in 16th chromosome. It consists of 3 exons. Today about 150 
polymorphisms of VKORC1 gene have been described. The most 
important are T2255C and G37300A. That there is no such a data as for 
Ukrainian populations.  
The aim of our research was to perform a case-control study on 
representatives of the Ukrainian population in order to assess the possible 
association of the VKORC1 gene polymorphisms with IAS in subjects of 
both genders.  
G3730A polymorphism (rs7294) of VKORС1 gene was determined in 
170 patients with AIS and in 124 persons of the control group by using 
PCR with restriction fragment length analysis. DNA for genotyping was 
extracted from venous blood using commercially available kits («Isogene 
Lab Ltd», Russian Federation) according to the manufacturer’s protocol. To 
identify the VKORС1 2nd intron T2255C polymorphism (rs2359612), PCR 
with subsequent restriction fragment length polymorphism (RFLP) analysis 
was performed. Specific region of the VKORС1 gene was amplified using 
a pair of specific primers. Primers were provided by Metabion (Germany). 
PCR was performed for 33 cycles in a 25 µl volume containing 50 –   100 
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ng of DNA, 5 µl 5 ´ PCRbuffer, 1.5 mM magnesium sulfate, 200 µM of 
each dNTP, 20 pM of each primer and 0.5 U of Taq DNA polymerase 
(«Fermentas», Lithuania). PCR was carried out in a termocycler GeneAmp 
PCR System 2700 («Applied Biosystems», USA). Six microlitres of the 
PCR products (198 bp) were subjected to digestion with 3 U NcoI 
(«Fermentas») and incubated at 37 oC for 18 h. The presence of cytosine at 
position 2255 of the gene VKORС1 prevents restriction and in the case of 
substitution for thymine NcoI cleaves the amplified fragment of the 
promoter into two fragments of 172 bp and 26 bp in length Statistical 
analysis was performed by using the software package SPSS-17. 
We received the following results. For polymorphism T2255C. 
Processing of these data using the chi-squared test confirmed a statistically 
significant difference between the distribution of different variants of the 
T2255C polymorphism of VKORC1 gene in patients with ischemic 
atherothrombotic stroke and in healthy people (P = 0.043). Method of 
logistic regression showed that the risk of stroke in carriers of CC genotype 
in 2.2 times higher than in patients with genotype TT. Chi-square criteria 
did not reveal any differences in the distribution of genotypes not in women 
and not in men. However, the method of logistic regression showed that the 
risk of stroke in men with the CC genotype in 2.5 times higher than carriers 
of TT genotype. As for polymorphism G3730A. The frequency of allelic 
variants was not statistically different in patients with stroke and among 
healthy people. The frequency of allelic variants was not statistically 
different in woman and in man.  
Based on these results we made following conclusions: 
1. Allelic polymorphism T2255C of the VKORC1 gene is an important 
factor for a genetic predisposition to the development of ischemic 
atherotrombotic stroke. There is an association of this polymorphism with 
development of ischemic stroke in the Ukrainian population: the risk of 
stroke in homozygotes for the minor allele higher than in carriers of the TT 
genotype.  
2. There is no association G3730A polymorphism with ischemic stroke 
in Ukrainian population.  
3. Effect of polymorphism T2255C, but not G3730A polymorphism in 
the development of ischemic stroke has sexual features: men with a CC 
genotype in 2.5 times more frequent suffer a stroke than men with genotype 
TT. 
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